fNIRS as a Biomarker for Preoperative Assessment: Correlating Brain Activity with Clinical Evaluation for Lumbar Disc Herniation
Abstract
1. Introduction
2. Materials and Methods
2.1. Subjects
2.2. fNIRS Recording
2.3. Experimental Procedure
2.4. fNIRS Data Analysis
2.5. Statistical Analysis
3. Results
3.1. Clinical Data and Evaluation Analysis of the Patient
3.2. fNIRS Brain Function Differences: LDH Group and HC
3.3. The Relationship Between fNIRS and Clinical Scales
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| LBP | Low back pain |
| LDH | Lumbar disc herniation |
| PM | Pain matrices |
| fMIR | Functional magnetic resonance imaging |
| EEG | Electroencephalogram |
| UBE | Unilateral Biportal Endoscopy |
| fNIRS | functional near-infrared spectroscopy |
| zfALFF | z-standardized Fractional Amplitude of Low-Frequency Fluctuations |
| FC | Functional connectivity |
| PFC | prefrontal cortex |
| mPFC | medial prefrontal cortex |
| PMC | premotor cortex |
| CLBP | chronic low back pain |
| PSC | primary somatosensory cortex |
| DLPFC | dorsolateral prefrontal cortex |
| HbO2 | oxyhemoglobin |
Appendix A
| Number | FC Matrix | Clinical Indicator | Partial Correlation Coefficient | FDR | Sig | Related Direction |
|---|---|---|---|---|---|---|
| 1 | 05-13 | VAS_MAX | 0.343 | 4.1502 × 10−3 | ** | positive |
| 2 | 13-15 | SF36_SF | −0.270 | <1.0 × 10−4 | *** | negative |
| 3 | 13-21 | ODI | 0.243 | <1.0 × 10−4 | *** | positive |
| 4 | 13-28 | SF36_SF | −0.237 | <1.0 × 10−4 | *** | negative |
| 5 | 13-02 | SF36_SF | −0.230 | <1.0 × 10−4 | *** | negative |
| 6 | 12-28 | SF36_VT | 0.200 | <1.0 × 10−4 | *** | positive |
| 7 | 12-28 | SF36_MH | −0.196 | <1.0 × 10−4 | *** | negative |
| 8 | 02-28 | SF36_MH | −0.196 | 4.1502 × 10−3 | ** | negative |
| 9 | 02-23 | VAS_MAX | 0.177 | 4.1502 × 10−3 | ** | positive |
| 10 | 05-20 | SF36_GH | 0.144 | 4.1502 × 10−3 | ** | positive |
| 11 | 06-09 | JOA | 0.141 | 4.1502 × 10−3 | ** | positive |
| 12 | 12-26 | SF36_MH | −0.143 | <1.0 × 10−4 | *** | negative |
| 13 | 14-13 | VAS_Lumbar | 0.137 | <1.0 × 10−4 | *** | positive |
| 14 | 05-26 | VAS_MAX | 0.133 | 4.1502 × 10−3 | ** | positive |
| 15 | 14-21 | VAS_Leg | −0.133 | <1.0 × 10−4 | *** | negative |
| 16 | 13-26 | SF36_MH | −0.137 | <1.0 × 10−4 | *** | negative |
| 17 | 05-06 | SF36_GH | 0.123 | 4.1502 × 10−3 | ** | positive |
| 18 | 13-17 | SF36_GH | 0.122 | <1.0 × 10−4 | *** | positive |
| 19 | 05-02 | VAS_Leg | 0.130 | 4.1502 × 10−3 | ** | positive |
| 20 | 13-23 | VAS_MAX | 0.115 | <1.0 × 10−4 | *** | positive |
| 21 | 14-17 | SF36_PF | 0.105 | <1.0 × 10−4 | *** | positive |
| 22 | 05-28 | VAS_Lumbar | 0.102 | 4.1502 × 10−3 | ** | positive |
| 23 | 05-16 | SF36_MH | 0.100 | 4.1502 × 10−3 | ** | positive |
| 24 | 05-18 | SF36_SF | −0.082 | 4.1502 × 10−3 | ** | negative |
| 25 | 14-06 | SF36_RP | 0.078 | <1.0 × 10−4 | *** | positive |
| 26 | 14-02 | SF36_GH | 0.075 | <1.0 × 10−4 | *** | positive |
| 27 | 05-15 | VAS_Lumbar | 0.073 | 4.1502 × 10−3 | ** | positive |
| 28 | 06-16 | SF36_VT | −0.072 | 4.1502 × 10−3 | ** | negative |
| 29 | 06-01 | SF36_MH | −0.092 | 4.1502 × 10−3 | ** | negative |
| 30 | 14-15 | SF36_BP | 0.069 | <1.0 × 10−4 | *** | positive |
| 31 | 13-06 | ODI | 0.069 | <1.0 × 10−4 | *** | positive |
| 32 | 13-11 | SF36_PF | 0.093 | <1.0 × 10−4 | *** | positive |
| 33 | 12-25 | VAS_Lumbar | −0.076 | <1.0 × 10−4 | *** | negative |
| 34 | 06-05 | SF36_SF | 0.055 | 4.1502 × 10−3 | ** | positive |
| 35 | 14-09 | ODI | 0.059 | <1.0 × 10−4 | *** | positive |
| 36 | 13-09 | SF36_BP | −0.059 | <1.0 × 10−4 | *** | negative |
| 37 | 02-27 | VAS_Lumbar | 0.063 | 4.1502 × 10−3 | ** | positive |
| 38 | 12-28 | SF36_GH | 0.050 | <1.0 × 10−4 | *** | positive |
| 39 | 05-22 | SF36_RP | −0.049 | 4.1502 × 10−3 | ** | negative |
| 40 | 06-18 | SF36_BP | −0.045 | 4.1502 × 10−3 | ** | negative |
| 41 | 05-09 | SF36_RP | 0.046 | 4.1502 × 10−3 | ** | positive |
| 42 | 13-25 | VAS_Lumbar | −0.058 | <1.0 × 10−4 | *** | negative |
| 43 | 05-01 | SF36_SF | 0.048 | 4.1502 × 10−3 | ** | positive |
| 44 | 05-24 | ODI | 0.037 | 4.1502 × 10−3 | ** | positive |
| 45 | 06-14 | SF36_RE | 0.035 | 4.1502 × 10−3 | ** | positive |
| 46 | 13-13 | SF36_BP | −0.040 | <1.0 × 10−4 | *** | negative |
| 47 | 13-19 | SF36_RP | 0.040 | <1.0 × 10−4 | *** | positive |
| 48 | 05-11 | ODI | 0.032 | 4.1502 × 10−3 | ** | positive |
| 49 | 13-06 | SF36_VT | −0.027 | <1.0 × 10−4 | *** | negative |
| 50 | 02-26 | SF36_RE | −0.062 | 4.1502 × 10−3 | ** | negative |
| 51 | 02-26 | SF36_SF | −0.029 | 4.1502 × 10−3 | ** | negative |
| 52 | 06-12 | SF36_HT | −0.029 | 4.1502 × 10−3 | ** | negative |
| 53 | 02-25 | VAS_Lumbar | 0.020 | 4.1502 × 10−3 | ** | positive |
| 54 | 14-11 | VAS_MAX | 0.011 | <1.0 × 10−4 | *** | positive |
| 55 | 06-11 | VAS_Leg | −0.003 | 4.1502 × 10−3 | ** | negative |
| 56 | 14-19 | JOA | −0.002 | <1.0 × 10−4 | *** | negative |
Appendix B


References
- GBD DAII. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018, 392, 1789–1858. [Google Scholar] [CrossRef]
- Petersen, T.; Laslett, M.; Juhl, C. Clinical classification in low back pain: Best-evidence diagnostic rules based on systematic reviews. BMC Musculoskel Dis. 2017, 18, 188. [Google Scholar] [CrossRef] [PubMed]
- Knezevic, N.N.; Candido, K.D.; Vlaeyen, J.; Van Zundert, J.; Cohen, S.P. Low back pain. Lancet 2021, 398, 78–92. [Google Scholar] [CrossRef] [PubMed]
- Hooten, W.M.; Cohen, S.P. Evaluation and Treatment of Low Back Pain: A Clinically Focused Review for Primary Care Specialists. Mayo Clin. Proc. 2015, 90, 1699–1718. [Google Scholar] [CrossRef] [PubMed]
- Tang, Y.; Zhang, Z.; Wu, Z.; Jin, Z.; Gong, Y.; Zhang, W.; Cheng, K.; Zhou, J.; Tong, P.; Xu, T.; et al. Impact of first ambulation time on unilateral biportal endoscopy in lumbar disc herniation: A systematic review and meta-analysis. Int. J. Surg. 2025, 111, 6362–6373. [Google Scholar] [CrossRef]
- Reis, J.O.P.G.; Pinto, E.M.; Teixeira, A.; Frada, R.; Rodrigues, D.; Cunha, R.; Miranda, A. Unilateral biportal endoscopy: Review and detailed surgical approach to extraforaminal approach. EFORT Open Rev. 2025, 10, 151–155. [Google Scholar] [CrossRef]
- Garcia-Larrea, L.; Peyron, R. Pain matrices and neuropathic pain matrices: A review. Pain 2013, 154, S29–S43. [Google Scholar] [CrossRef]
- Lu, Y.; Klein, G.T.; Wang, M.Y. Can pain be measured objectively? Neurosurgery 2013, 73, N24–N25. [Google Scholar] [CrossRef]
- Wager, T.D.; Atlas, L.Y.; Lindquist, M.A.; Roy, M.; Woo, C.; Kross, E. An fMRI-based neurologic signature of physical pain. N. Engl. J. Med. 2013, 368, 1388–1397. [Google Scholar] [CrossRef]
- Zhou, Z.; Hui, E.S.; Kranz, G.S.; Chang, J.R.; de Luca, K.; Pinto, S.M.; Chan, W.W.; Yau, S.Y.; Chau, B.K.; Samartzis, D.; et al. Potential mechanisms underlying the accelerated cognitive decline in people with chronic low back pain: A scoping review. Ageing Res. Rev. 2022, 82, 101767. [Google Scholar] [CrossRef]
- Chen, W.; Wagner, J.; Heugel, N.; Sugar, J.; Lee, Y.; Conant, L.; Malloy, M.; Heffernan, J.; Quirk, B.; Zinos, A.; et al. Functional Near-Infrared Spectroscopy and Its Clinical Application in the Field of Neuroscience: Advances and Future Directions. Front. Neurosci. 2020, 14, 724. [Google Scholar] [CrossRef] [PubMed]
- Mussigmann, T.; Bardel, B.; Lefaucheur, J. Resting-state electroencephalography (EEG) biomarkers of chronic neuropathic pain. A systematic review. Neuroimage 2022, 258, 119351. [Google Scholar] [CrossRef] [PubMed]
- Han, Y.; Zeng, X.; Hua, L.; Quan, X.; Chen, Y.; Zhou, M.; Chuang, Y.; Li, Y.; Wang, S.; Shen, X.; et al. The fusion of multi-omics profile and multimodal EEG data contributes to the personalized diagnostic strategy for neurocognitive disorders. Microbiome 2024, 12, 12. [Google Scholar] [CrossRef] [PubMed]
- May, E.S.; Gil Ávila, C.; Dinh, S.T.; Heitmann, H.; Hohn, V.D.; Nickel, M.M.; Tiemann, L.; Tölle, T.R.; Ploner, M. Dynamics of brain function in patients with chronic pain assessed by microstate analysis of resting-state electroencephalography. Pain 2021, 162, 2894–2908. [Google Scholar] [CrossRef] [PubMed]
- Karunakaran, K.D.; Peng, K.; Berry, D.; Green, S.; Labadie, R.; Kussman, B.; Borsook, D. NIRS measures in pain and analgesia: Fundamentals, features, and function. Neurosci. Biobehav. Rev. 2021, 120, 335–353. [Google Scholar] [CrossRef]
- Li, R.; Shao, W.; Zhao, S.; Wang, L.; Yu, C.; Liu, L.; Yin, K. EEG alpha/beta features as a biomarker for quantifying pain in patients with lumbar disk herniation. Front. Neurosci. 2025, 19, 1507245. [Google Scholar] [CrossRef]
- Zeng, X.; Tang, W.; Gao, F.; Tang, Z.; Zhang, Z.; Zhang, J.; Du, M.; Chen, Z.; Chen, X.; Yuan, Z. Behavioral modeling and neuroimaging of impaired risky decision making in patients with chronic musculoskeletal pain. Neurophotonics 2023, 10, 20901. [Google Scholar] [CrossRef]
- Zhang, L.; Chen, Y.; Li, Z.; Geng, X.; Zhao, X.; Zhang, F.; Bi, Y.; Lu, X.; Hu, L. Advances and challenges in neuroimaging-based pain biomarkers. Cell Rep. Med. 2024, 5, 101784. [Google Scholar] [CrossRef]
- Hou, X.; Zhang, Z.; Zhao, C.; Duan, L.; Gong, Y.; Li, Z.; Zhu, C. NIRS-KIT: A MATLAB toolbox for both resting-state and task fNIRS data analysis. Neurophotonics 2021, 8, 10802. [Google Scholar] [CrossRef]
- Wang, H.; Liu, X.; Zhang, G. Cortical functional mechanism of impaired postural control in patients with chronic low back pain: A fNIRS study. Chin. J. Rehabil. Med. 2025, 40, 661–672. [Google Scholar]
- Zeng, X.; Tang, W.; Yang, J.; Lin, X.; Du, M.; Chen, X.; Yuan, Z.; Zhang, Z.; Chen, Z. Diagnosis of Chronic Musculoskeletal Pain by Using Functional Near-Infrared Spectroscopy and Machine Learning. Bioengineering 2023, 10, 669. [Google Scholar] [CrossRef] [PubMed]
- Berchansky, M.; Evins, A.E.; Evohr, B.; Himmelsbach, Z.; Pachas, G.N.; Karunakaran, K.D.; Laufer Goldshtein, B.; Ozana, N.; Gilman, J.M. Detection of Δ9-Tetrahydrocannabinol Impairment Using Resting-State Functional Near-Infrared Spectroscopy: A Randomized Clinical Trial. JAMA Netw. Open 2026, 9, e2556647. [Google Scholar] [CrossRef] [PubMed]
- Chen, L.; Du, B.; Li, K.; Li, K.; Hou, T.; Jia, F.; Li, L. The effect of tDCS on inhibitory control and its transfer effect on sustained attention in children with autism spectrum disorder: An fNIRS study. Brain Stimul. 2024, 17, 594–606. [Google Scholar] [CrossRef]
- Shao, K.; Liu, Y.; Mo, Y.; Yang, Q.; Hao, Y.; Chen, M. fNIRS-Driven Depression Recognition Based on Cross-Modal Data Augmentation. IEEE Trans. Neural Syst. Rehabil. Eng. 2024, 32, 2688–2698. [Google Scholar] [CrossRef]
- Ho, C.S.H.; Wang, J.; Tay, G.W.N.; Ho, R.; Lin, H.; Li, Z.; Chen, N. Application of functional near-infrared spectroscopy and machine learning to predict treatment response after six months in major depressive disorder. Transl. Psychiat 2025, 15, 7. [Google Scholar] [CrossRef]
- Rosas-Romero, R.; Guevara, E.; Peng, K.; Nguyen, D.K.; Lesage, F.; Pouliot, P.; Lima-Saad, W. Prediction of epileptic seizures with convolutional neural networks and functional near-infrared spectroscopy signals. Comput. Biol. Med. 2019, 111, 103355. [Google Scholar] [CrossRef]
- Wang, C.; Ellingson, B.M.; Oughourlian, T.C.; Salamon, N.; Holly, L.T. Evolution of brain functional plasticity associated with increasing symptom severity in degenerative cervical myelopathy. eBioMedicine 2022, 84, 104255. [Google Scholar] [CrossRef]
- Qu, J.; Du, Y.; Jing, J.; Wang, J.; Bu, L.; Wang, Y. Short-Term Longitudinal Study on Brain Network Informatics of Stroke Patients Under Acupuncture and Motor Imagery Intervention. IEEE J. Biomed. Health 2025, 29, 3356–3365. [Google Scholar] [CrossRef]
- Fallgatter, A.J.; Roesler, M.; Sitzmann, L.; Heidrich, A.; Mueller, T.J.; Strik, W.K. Loss of functional hemispheric asymmetry in Alzheimer’s dementia assessed with near-infrared spectroscopy. Brain Res. Cogn. Brain Res. 1997, 6, 67–72. [Google Scholar] [CrossRef]
- Lee, T.; Guo, L.; Chan, A.S. fNIRS as a biomarker for individuals with subjective memory complaints and MCI. Alzheimer’s Dement. J. Alzheimer’s Assoc. 2024, 20, 5170–5182. [Google Scholar] [CrossRef]





| LDH | |||
|---|---|---|---|
| Total case | 67 | ||
| Age (years) | 52.64 ± 15.13 | ||
| Height (cm) | 164.12 ± 9.51 | ||
| Weight (kg) | 67.19 ± 13.99 | ||
| BMI | 24.80 ± 3.69 | ||
| Gender | male | 41 | |
| female | 26 | ||
| With LSS | yes | 43 | |
| no | 24 | ||
| Surgical segment | single | ||
| 50 | L2/3 | 2 | |
| L3/4 | 3 | ||
| L4/5 | 30 | ||
| L5/S1 | 15 | ||
| multiple | |||
| 14 | L3/4-L4/5 | 4 | |
| L4/5-L5/S1 | 10 | ||
| Operating time (min) | 117 ± 39.17 | ||
| Intraoperative Blood Loss (mL) | 28.73 ± 18.56 | ||
| Number | FC Matrix | Clinical Indicator | Partial Correlation Coefficient | FDR | Sig | Related Direction |
|---|---|---|---|---|---|---|
| 1 | 05-13 | VAS_MAX | 0.343 | 4.1502 × 10−3 | ** | Positive |
| 2 | 13-15 | SF36_SF | −0.270 | <1.0 × 10−4 | *** | negative |
| 3 | 13-21 | ODI | 0.243 | <1.0 × 10−4 | *** | Positive |
| 4 | 13-28 | SF36_SF | −0.237 | <1.0 × 10−4 | *** | negative |
| 5 | 13-02 | SF36_SF | −0.230 | <1.0 × 10−4 | *** | negative |
| 6 | 12-28 | SF36_VT | 0.200 | <1.0 × 10−4 | *** | Positive |
| 7 | 12-28 | SF36_MH | −0.196 | <1.0 × 10−4 | *** | negative |
| 8 | 02-28 | SF36_MH | −0.196 | 4.1502 × 10−3 | ** | negative |
| 9 | 02-23 | VAS_MAX | 0.177 | 4.1502 × 10−3 | ** | Positive |
| 10 | 05-20 | SF36_GH | 0.144 | 4.1502 × 10−3 | ** | Positive |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Huang, C.; Li, C.; Su, Z.; Guo, Q.; Wang, Q.; Chen, T.; Wang, Y.; Yuan, Z.; Lu, H. fNIRS as a Biomarker for Preoperative Assessment: Correlating Brain Activity with Clinical Evaluation for Lumbar Disc Herniation. Bioengineering 2026, 13, 508. https://doi.org/10.3390/bioengineering13050508
Huang C, Li C, Su Z, Guo Q, Wang Q, Chen T, Wang Y, Yuan Z, Lu H. fNIRS as a Biomarker for Preoperative Assessment: Correlating Brain Activity with Clinical Evaluation for Lumbar Disc Herniation. Bioengineering. 2026; 13(5):508. https://doi.org/10.3390/bioengineering13050508
Chicago/Turabian StyleHuang, Chengjie, Changqing Li, Zhihai Su, Qiwei Guo, Quan Wang, Tao Chen, Yuhan Wang, Zhen Yuan, and Hai Lu. 2026. "fNIRS as a Biomarker for Preoperative Assessment: Correlating Brain Activity with Clinical Evaluation for Lumbar Disc Herniation" Bioengineering 13, no. 5: 508. https://doi.org/10.3390/bioengineering13050508
APA StyleHuang, C., Li, C., Su, Z., Guo, Q., Wang, Q., Chen, T., Wang, Y., Yuan, Z., & Lu, H. (2026). fNIRS as a Biomarker for Preoperative Assessment: Correlating Brain Activity with Clinical Evaluation for Lumbar Disc Herniation. Bioengineering, 13(5), 508. https://doi.org/10.3390/bioengineering13050508

